SMT201300013B - Lixisenatide come terapia aggiuntiva a insulina glargina e metformina per il trattamento del diabetedi tipo 2 - Google Patents

Lixisenatide come terapia aggiuntiva a insulina glargina e metformina per il trattamento del diabetedi tipo 2

Info

Publication number
SMT201300013B
SMT201300013B SM201300013T SM201300013T SMT201300013B SM T201300013 B SMT201300013 B SM T201300013B SM 201300013 T SM201300013 T SM 201300013T SM 201300013 T SM201300013 T SM 201300013T SM T201300013 B SMT201300013 B SM T201300013B
Authority
SM
San Marino
Prior art keywords
lixisenatide
metformin
diabetes
treatment
type
Prior art date
Application number
SM201300013T
Other languages
English (en)
Italian (it)
Inventor
Louise Silvestre
Elisabeth Souhami
Xiaodan Wei
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41800749&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT201300013(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of SMT201300013B publication Critical patent/SMT201300013B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
SM201300013T 2009-11-13 2013-01-30 Lixisenatide come terapia aggiuntiva a insulina glargina e metformina per il trattamento del diabetedi tipo 2 SMT201300013B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09175877.1A EP2329848B2 (en) 2009-11-13 2009-11-13 Lixisenatide as add-on therapy to insulin glargine and metformin for treating type 2 diabetes

Publications (1)

Publication Number Publication Date
SMT201300013B true SMT201300013B (it) 2013-03-08

Family

ID=41800749

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201300013T SMT201300013B (it) 2009-11-13 2013-01-30 Lixisenatide come terapia aggiuntiva a insulina glargina e metformina per il trattamento del diabetedi tipo 2

Country Status (11)

Country Link
EP (1) EP2329848B2 (sr)
CY (1) CY1113755T1 (sr)
DK (1) DK2329848T4 (sr)
ES (1) ES2398012T5 (sr)
HR (1) HRP20121029T4 (sr)
ME (1) ME01546B (sr)
PL (1) PL2329848T5 (sr)
PT (1) PT2329848E (sr)
RS (1) RS52629B2 (sr)
SI (1) SI2329848T2 (sr)
SM (1) SMT201300013B (sr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010043566A2 (de) 2008-10-17 2010-04-22 Sanofi-Aventis Deutschland Gmbh Kombination von einem insulin und einem glp-1-agonisten
US9707176B2 (en) 2009-11-13 2017-07-18 Sanofi-Aventis Deutschland Gmbh Pharmaceutical composition comprising a GLP-1 agonist and methionine
ES2855146T3 (es) 2009-11-13 2021-09-23 Sanofi Aventis Deutschland Composición farmacéutica que comprende un agonista de GLP-1, una insulina y metionina
AU2011202239C1 (en) 2010-05-19 2017-03-16 Sanofi Long-acting formulations of insulins
PT2611458T (pt) 2010-08-30 2016-12-16 Sanofi Aventis Deutschland Utilização de ave0010 para o fabrico de um medicamento para o tratamento da diabetes mellitus tipo 2
CA2825162A1 (en) * 2011-02-02 2012-08-09 Sanofi-Aventis Deutschland Gmbh Prevention of hypoglycaemia in diabetes mellitus type 2 patients
US9821032B2 (en) * 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
PT2750699E (pt) 2011-08-29 2015-11-03 Sanofi Aventis Deutschland Acelerómetro pendular
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
WO2013060850A1 (en) * 2011-10-28 2013-05-02 Sanofi-Aventis Deutschland Gmbh Treatment protocol of diabetes type 2
CA2907848A1 (en) 2013-04-03 2014-10-09 Sanofi Treatment of diabetes mellitus by long-acting formulations of insulins
LT3010530T (lt) * 2013-06-17 2019-04-10 Sanofi-Aventis Deutschland Gmbh Kompozicija su fiksuotu insulino glargino / liksisenatido santikiu
CN107206058A (zh) 2014-12-12 2017-09-26 赛诺菲-安万特德国有限公司 甘精胰岛素/利西拉来固定比率配制剂
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1076066A1 (en) 1999-07-12 2001-02-14 Zealand Pharmaceuticals A/S Peptides for lowering blood glucose levels

Also Published As

Publication number Publication date
HRP20121029T4 (hr) 2019-10-18
ME01546B (me) 2014-04-20
HRP20121029T1 (hr) 2013-01-31
RS52629B (sr) 2013-06-28
EP2329848B1 (en) 2012-10-24
DK2329848T4 (da) 2019-09-09
DK2329848T3 (da) 2013-02-04
PL2329848T5 (pl) 2019-12-31
PL2329848T3 (pl) 2013-05-31
ES2398012T3 (es) 2013-03-13
EP2329848B2 (en) 2019-06-19
PT2329848E (pt) 2013-01-23
RS52629B2 (sr) 2019-11-29
ES2398012T5 (es) 2020-02-26
SI2329848T1 (sl) 2013-02-28
CY1113755T1 (el) 2016-07-27
SI2329848T2 (sl) 2019-10-30
EP2329848A1 (en) 2011-06-08

Similar Documents

Publication Publication Date Title
SMT201300013B (it) Lixisenatide come terapia aggiuntiva a insulina glargina e metformina per il trattamento del diabetedi tipo 2
NL300883I2 (nl) insulin glargine/lixisenatide
HRP20170209T1 (hr) Liksisenatid kao dodatna terapija uz bazalni inzulin kod dijabetesa tipa 2
PL2324853T3 (pl) Liksysenatyd jako dodatek do metforminy w leczeniu cukrzycy typu 2
HK1256637A1 (zh) 用於治療或預防心力衰竭的神經調節蛋白或其亞序列的治療性施劑
PT2611458T (pt) Utilização de ave0010 para o fabrico de um medicamento para o tratamento da diabetes mellitus tipo 2
PL2707017T3 (pl) Liksisenatyd i metformina do leczenia cukrzycy typu 2
IL219945A (en) 1-GLP history with dual transduction and use of it to prepare a drug for the treatment of diabetes
IL212903A0 (en) Treatment of diabetes in patients with inadequate glycemic control despite metformin therapy comprising a dpp-iv inhibitor
IL209887A0 (en) Treatment for diabetes in patients inappropriate for metformin therapy
BR112013029256A2 (pt) "combinações farmacêuticas para uso no tratamento de pacientes com diabetes tipo 2, método de tratamento, e usos de lixisenatida e metformina".
GB0919603D0 (en) Use of thymosin beta-4 for treatment of type II diabetes
SG10201601210YA (en) Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
TH0901003547A (th) การรักษาสำหรับโรคเบาหวานในคนไข้ที่ไม่เหมาะสำหรับการรักษาด้วยเมทฟอร์มิน
BR112013031487A2 (pt) combinação sinérgica para o tratamento de diabetes mellitus tipo 2
TH0901004644A (th) สารประกอบสไปโร-ออกซินดอล และการใช้สารเป็นยารักษาโรค
ZA201008998B (en) Treatment for diabetes in patients inappropriate for metformin therapy
GB0904178D0 (en) General cure to diseases idea 3
TH0901003991A (th) สารประกอบที่เชื่อมต่อกับซัลเฟอร์สำหรับการบำบัดโรค และความผิดปกติที่เกี่ยวกับตา